Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru

Value in Health

English

Cost-Effectiveness of Nivolumab (NIVO) Combined With Ipilimumab (IPI) Compared With Nivo and Ipi Monotherapies in the First-Line Treatment of Advanced Melanoma in the United States: Analysis Using 28-Month Overall Survival (OS) Data From Checkmate 067

English

Pms60 - Clinical and Economic "Real World” Analysis of the Switching From Remicade (Infliximabe) by Remsima (Infliximab Biossimilar) of Planserv Patients With Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis.

English

Primary Care Physicians in an Interferon-Free World: Could Safer, More Efective Oral Hepatitis C Therapies Lead to Improved Outcomes Through Education and PCP-Prescribed Treatment?

English

Budget Impact Analysis of Delayed-Release Dimethylfumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy

English

Drug-Safety Program Impact at Health Care Perception at Patients Diagnosed With Persistent Severe Asthma

English

PCN6 the Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practice

English

Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic

English

Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs

English

Hypercholesterolemia’s Burden of Disease in Portugal

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Cost-Effectiveness of Atazanavir/Ritonavir Against Lopinavir/Ritonavir in the Treatment of People Living With Hiv in Peru

Cost-Effectiveness of Nivolumab (NIVO) Combined With Ipilimumab (IPI) Compared With Nivo and Ipi Monotherapies in the First-Line Treatment of Advanced Melanoma in the United States: Analysis Using 28-Month Overall Survival (OS) Data From Checkmate 067

Pms60 - Clinical and Economic "Real World” Analysis of the Switching From Remicade (Infliximabe) by Remsima (Infliximab Biossimilar) of Planserv Patients With Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis.

Primary Care Physicians in an Interferon-Free World: Could Safer, More Efective Oral Hepatitis C Therapies Lead to Improved Outcomes Through Education and PCP-Prescribed Treatment?

Budget Impact Analysis of Delayed-Release Dimethylfumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy

Drug-Safety Program Impact at Health Care Perception at Patients Diagnosed With Persistent Severe Asthma

PCN6 the Evaluation of the Use and Effectiveness of Bevacizumab for Patients With Metastatic Renal Cell Carcinoma in Daily Practice

Cost-Effectiveness Analysis of Atorvastatin Compared to Simvastatin in the Prevention of Cardiovascular Diseases in the Czech Republic

Bayesian Models for Cost-Effectiveness Analysis in the Presence of Structural Zero Costs

Hypercholesterolemia’s Burden of Disease in Portugal